scholarly journals Effects of therapeutic plasma exchange on liver function test and coagulation parameters in acute liver failure patients

2020 ◽  
Vol 42 (2) ◽  
pp. 125-128 ◽  
Author(s):  
Ashish Maheshwari ◽  
Meenu Bajpai ◽  
Gopal Kumar Patidar
2019 ◽  
Vol 5 (6) ◽  
pp. 204-207
Author(s):  
Dr. Mohini Singh ◽  
◽  
Dr. Srilakshmi Sathiyaseelan ◽  
Devarasetty Shashank ◽  
Dr. S.R. Ramakrishnan ◽  
...  

Acute liver failure (ALF) is a condition with rapid deterioration of liver function resulting in hepatic encephalopathy and/or coagulopathy in patients with previously normal liver. Acute liver failure (ALF) is an uncommon condition associated with high morbidity and mortality. The prognosis is poor for untreated cases of Acute liver failure, so early recognition and management of patients with acute liver failure is crucial. A cause for acute liver failure can be identified in 60 to 80 percent of patients. Identifying the underlying cause of the liver failure is important because it influences the approach to management and provides prognostic information. Aims and Objectives: The aim of our study is to identify the clinical features, etiology and outcome of acute liver failure in a tertiary care hospital. Materials and Methods: This study is an observational study where patients with Acute Liver Failure admitted in ICU in our institution after meeting the diagnostic criteria for Acute liver failure were included in the study. Details of history, relevant symptoms and baseline investigations included, complete blood count, blood glucose, renal function test, serum electrolytes, liver function test (LFT), prothrombin time, international normalized ratio (INR), lactate dehydrogenase (LDH), creatine kinase (CK)], arterial blood gas analysis, arterial lactate, arterial ammonia, amylase and lipase level and pregnancy test (if female) and ultrasonography (USG) abdomen were recorded, MRI brain and other investigations relevant to the admission diagnosis, co morbidities and aetiology if needed were recorded. All the patients received standard supportive treatment for ALF. Results: In this study of 57 patients, majority of the patients were from the age group 41 to 50 years (17 patients) and 31 to 40 years (13 patients). 36 patients were male and 21 patients were females. Jaundice and encephalopathy was observed in all 57 (100%) patients, 24 (42%) patients had INR >2.5, 27 (47%) patients had serum creatinine >1.2 mg/dl and 18 (31.5%) patients had serum ammonia levels >100 micromol/L. The lowest value for serum aminotranferase was observed in infections (other than viral hepatitis) and maximum value was observed in drugs leading to ALF.In 20 (35%) patients viral hepatitis was the cause for ALD, followed by drugs and toxins which was the cause of ALD in 18 (31.5%) patients. Infections other viral hepatitis as the aetiology for ALF was observed in 16 (28%) of patients. Ischemic hepatitis was observed in 1 and Wilson’s disease was noted in 2 patients. Total 6 (10.5%) patients out of 57 patients had died, 4 patients with hepatitis B infection, 1 patient with paracetamol over dosage and 1 patient with dengue fever had died. Conclusion: Viral hepatitis and drugs are the commonest cause for acute liver failure. The aetiology of ALF varies significantly worldwide. Determining the etiology of acute liver failure requires a combination of detailed history taking and investigations. A broad evaluation is required to identify a cause of the acute liver failure, as the prognosis is poor in untreated cases of acute liver failure, so early recognition and management of patients with acute liver failure is crucial.


2019 ◽  
Vol 34 (5) ◽  
pp. 589-597 ◽  
Author(s):  
Klaus Stahl ◽  
Johannes Hadem ◽  
Andrea Schneider ◽  
Michael P. Manns ◽  
Olaf Wiesner ◽  
...  

2013 ◽  
Vol 28 (6) ◽  
pp. 426-429 ◽  
Author(s):  
Edward W. Holt ◽  
Jennifer Guy ◽  
Shelley M. Gordon ◽  
Jan C. Hofmann ◽  
Richard Garcia-Kennedy ◽  
...  

Author(s):  
Anooja Thampi

 Acute liver failure is a clinical entity associated with a high mortality rate and majority of these patients may require liver transplantation. N-Acetylcysteine (NAC), an antioxidant agent that replenishes mitochondrial and cytosolic glutathione stores, is an antidote for acetaminophen poisoning. But their role in non–acetaminophen-related acute liver failure is still not proven. Here, we discuss about a 67 year old male patient diagnosed with hepatitis with acute liver injury who was admitted in Emergency Medicine. He was treated with N- Acetylcysteine infusion for an average of 48 hours and later it was found that his liver function tests improved. In this study, we could find that N-Acetylcysteine plays a major role in improving the liver function test of patients with non–acetaminophen-related acute liver failure.


Author(s):  
Joy Varghese ◽  
Vivek Joshi ◽  
Madhan Kumar Bollipalli ◽  
Selvakumar Malleeswaran ◽  
Rajinikanth Patcha ◽  
...  

Critical Care ◽  
2010 ◽  
Vol 14 (Suppl 1) ◽  
pp. P510 ◽  
Author(s):  
D Demirkol ◽  
O Yanar ◽  
N Gerenli ◽  
A Citak ◽  
I Ozden ◽  
...  

2021 ◽  
Author(s):  
Chun-Feng Yang ◽  
Yu-Ao ◽  
Lin-Mei Jin ◽  
Yumei Li

Abstract We aims to assess the efficacy and safety of therapeutic plasma exchange (TPE) in pediatric acute liver failure (PALF) and to examine possible risk factors for mortality. Similar data are limited in PALF. Thirty-three cases diagnosed with PALF who received TPE from June 2011 to June 2021 in the pediatric intensive care unit (PICU) of the First Hospital of Jilin University were included in this retrospective cohort analysis. Descriptive statistics were used for the clinical features of these patients and TPE related variables. The effect of TPE was measured by the difference tests before and after treatment. Survivors with native livers and nonsurvivors were also compared by the difference tests. In the TPE combined with continuous renal replacement therapy (CRRT) group (21/33, 63.6%), the patients were older, and more patients had multiple organ dysfunction syndrome (76.2% vs 25%, P =0.009) and a greater need for mechanical ventilation (86.2% vs 8.3%, P <0.001). TPE can significantly reduce alanine aminotransferase, total bilirubin, and international normalized ratio . The most common complication in the overall population was hypocalcemia (n=12, 36%), while the most common complication in children under 2 years of age was hypotension (n=3, 40%). The mortality of liver transplant-free patients was 10/30 (30%). The nonsurvivor group had significantly more failed organs, longer PICU stays and more patients requiring ventilatory support. ConclusionsTPE alone or combined with CRRT can effectively improve liver function and may reduce mortality. TPE can be performed relatively safely in critically ill children, including younger patients.


Sign in / Sign up

Export Citation Format

Share Document